GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹515 Cr | ₹456 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr |
What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹515 Cr |
| Mar2025 | ₹456 Cr |
| Mar2024 | ₹387 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹355 Cr |
How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹515 Cr | 12.92 | |
| Mar2025 | ₹456 Cr | 17.78 | |
| Mar2024 | ₹387 Cr | 9.46 | |
| Mar2023 | ₹354 Cr | -0.26 | |
| Mar2022 | ₹355 Cr | - | |
Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,106.9 Cr | 0.9% | 9.7% | -24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.9% |
9.7% |
-24.3% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses